[1]
|
Hisakazu, K., Yamada, K. and Tamai, I. (2018) Hyperuricemia Enhances Intracellular Urate Accumulation via Down-Regulation of Cell-Surface BCRP/ABCG2 Expression in Vascular Endothelial Cells. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1860, 973-980. https://doi.org/10.1016/j.bbamem.2018.01.006
|
[2]
|
曾小峰, 陈耀龙. 2016中国痛风诊疗指南[J]. 浙江医学, 2017, 39(21): 1823-1832.
|
[3]
|
Haring, B., Kudlich, T., Rauthe, S., Melcher, R. and Geier, A. (2013) Benzbromarone: A Double-Edged Sword That Cuts the Liver? European Journal of Gastroenter-ology & Hepatology, 25, 119-121.
https://doi.org/10.1097/MEG.0b013e328358ace9
|
[4]
|
Khanna, P.P. (2018) Gout: A Patrician Malady No More. The Lancet Diabetes & Endocrinology, 6, 263-264.
https://doi.org/10.1016/S2213-8587(18)30073-1
|
[5]
|
Vitetta, L. and Gobe, G. (2013) Uremia and Chronic Kidney Disease: The Role of the Gut Microflora and Therapies with Pro-and Prebiotics. Molecular Nutrition & Food Research, 57, 824-832. https://doi.org/10.1002/mnfr.201200714
|
[6]
|
Wang, Z., Cui, T., Ci, X., Zhao, F., Sun, Y., Li, Y., et al. (2019) The Effect of Polymorphism of Uric Acid Transporters on Uric Acid Transport. Journal of Nephrology, 32, 177-187. https://doi.org/10.1007/s40620-018-0546-7
|
[7]
|
Ristic, B., Omar Faruk Sikder, M., Bhutia, Y. and Ga-napathy, V. (2020) Pharmacologic Inducers of the Uric Acid Exporter ABCG2 as Potential Drugs for Treatment of Gouty Arthritis. Asian Journal of Pharmaceutical Sciences, 15, 173-180. https://doi.org/10.1016/j.ajps.2019.10.002
|
[8]
|
Takeo, N., Kouhei, O., Sho, S., Anzai, N. and Tamai, I. (2013) Functional Cooperation of URAT1 (SLC22A12) and URATv1 (SLC2A9) in Renal Reabsorption of Urate. Nephrol Dial Transplant, 28, 603-611.
https://doi.org/10.1093/ndt/gfs574
|
[9]
|
Eleftheriadis, T., GolpHinopoulos, S., Pissas, G. and Stefanidis, I. (2017) Asymptomatic Hyperuricemia and Chronic Kidney Disease: Narrative review of A Treatment Controversial. Journal of Advanced Research, 8, 555-560.
https://doi.org/10.1016/j.jare.2017.05.001
|
[10]
|
Witkowska, K., Smith, K.M., Yao, S.Y.M., Ng, A.M.L., O’Neill, D., Karpinski, E., et al. (2012) Human SLC2A9a and SLC2A9b Isoforms Mediate Electrogenic Transport of Urate with Different Characteristics in the Presence of Hexoses. American Journal of Physiology-Renal Physiology, 303, F527-F539. https://doi.org/10.1152/ajprenal.00134.2012
|
[11]
|
Dinour, D., Gray, N.K., Campbell, S., Shu, X., Sawyer, L., Richardson, W., et al. (2010) Homozygous SLC2A9 Mutations Cause Severe Renal Hypouricemia. Journal of the Amer-ican Society of Nephrology, 21, 64-72.
https://doi.org/10.1681/ASN.2009040406
|
[12]
|
Kawamura, Y., Matsuo, H., Chiba, T., Nagamori, S., Nakayama, A., Inoue, H., et al. (2011) Pathogenic GLUT9 Mutations Causing Renal Hypouricemia Type 2 (RHUC2). Nucleosides, Nucleotides & Nucleic Acids, 30, 1105-1111.
https://doi.org/10.1080/15257770.2011.623685
|
[13]
|
Woodward, O.M., Kottgen, A., Coresh, J., Boerwinkle, E., Guggino, W.B. and Köttgen, M. (2009) Identification of a Urate Transporter, ABCG2, with a Common Functional Pol-ymorphism Causing Gout. Proceedings of the National Academy of Sciences of the United States of America, 106, 10338-10342. https://doi.org/10.1073/pnas.0901249106
|
[14]
|
Kazumasa, Y., Takeshi, T., Akihiko, K., Köttgen, A., Folsom, A.R. and Iso, H. (2010) The rs2231142 Variant of the ABCG2 Gene Is Associated with Uric Acid Levels and Gout among Japanese People. Rheumatology, 49, 1461-1465.
https://doi.org/10.1093/rheumatology/keq096
|
[15]
|
El-Sheikh, A.A.K., van den Heuvel, J.J.M.W., Koenderink, J.B., Koenderink, J.B. and Russel, F.G.M. (2010) Effect of Hypouricaemic and Hyperuricaemic Drugs on the Renal Urate Ef-flux Transporter, Multidrug Resistance Protein 4. British Journal of Pharmacology, 155, 1066-1075. https://doi.org/10.1038/bjp.2008.343
|
[16]
|
Tanner, C., Boocock, J., Stahl, E.A., Dobbyn, A., Mandal, A.K., Cad-zow, M., et al. (2017) Population-Specific Resequencing Associates the ATP-Binding Cassette Subfamily C Member 4 Gene with Gout in New Zealand Maori and Pacific Men. Arthritis & Rheumatology, 69, 1461-1469. https://doi.org/10.1002/art.40110
|
[17]
|
毛古燧, 黄传兵, 汪元, 付俊, 闫学朋. 尿酸转运蛋白在原发性痛风中的研究进展[J]. 安徽医药, 2017, 21(1): 7-10.
|
[18]
|
Bobulescu, I.A. and Moe, O.W. (2012) Renal Transport of Uric Acid: Evolving Concepts and Uncertainties. Advances in Chronic Kidney Disease, 19, 358-371. https://doi.org/10.1053/j.ackd.2012.07.009
|
[19]
|
Chiba, T., Matsuo, H., Kawamura, Y., Nagamori, S., Nishiyama, T., Wei, L., et al. (2015) NPT1/SLC17A1 Is a Renal Urate Exporter in Humans and Its Common Gain-of-Function Var-iant Decreases the Risk of Renal Underexcretion Gout. Arthritis & Rheumatology, 67, 281-287. https://doi.org/10.1002/art.38884
|
[20]
|
Jutabha, P., Anzai, N., Kimura, T., Taniguchi, A., Urano, W., Yamanaka, H., et al. (2010) Functional Analysis of Human Sodium-Phosphate Transporter 4 (NPT4/SLC17A3) Polymorphisms. Jour-nal of Pharmacological Sciences, 115, 249-253. https://doi.org/10.1254/jphs.10228SC
|
[21]
|
Yano, H., Tamura, Y., Kobayashi, K., Tanemoto, M. and Uchida, S. (2014) Uric Acid Transporter ABCG2 Is Increased in the Intestine of the 5/6 Nephrectomy Rat Model of Chronic kidney Disease. Clinical & Experimental Nephrology, 18, 50-55. https://doi.org/10.1007/s10157-013-0806-8
|